Studies have designated ATAD5 as a key biomarker for ovarian cancer; deficient ATAD5 activity is linked to impaired PCNA unloading from the DNA strand and increased genomic instability [93]. The gene discussed is ATAD5; the disease is ovarian carcinoma.